ENRICH Forum: Ethical and Regulatory Issues in Cancer Research: Secondary Research with Biological Samples and Data Under the Revised Common Rule
On Tuesday, September 24, Dr. Yvonne Lau will present about recent regulatory revisions to the Common Rule, 45 CFR part 46, concerning secondary research uses of biological samples and associated data. During the presentation, Dr. Lau will discuss the new provisions pertaining to the protection of identifiable information and identifiable biospecimens including:
- the mandated periodic review by federal agencies of technologies that generate identifiable data
- new exemption for information that is regulated under the HIPAA Privacy Rule
This event sponsored by NCI's Division of Cancer Control and Population Sciences' (DCCPS) Epidemiology and Genomics Research Program and NCI's Division of Cancer Treatment and Diagnosis' (DCTD) Cancer Diagnosis Program.
For more event information please contact Carol Weil at 240-276-5975 or Charlisse Caga-anan at 240-276-6738.
Dr. Yvonne Lau is the Director of the Division of Education and Development HHS' Office for Human Research Protections.
- NCI Imaging Data Commons Hosts 2022 RSNA Session: Towards Transparency and Reproducibility in Imaging AINovember 27, 2022 - November 30, 2022DataViz + Cancer Micro Lab: Using Data Visualization and Interactive Experiences to Advance Immuno-OncologyDecember 01, 2022